• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Innovation Iteration: Latest Advancements in Design & Prototyping

    Robot Recharge: Orthopedic Surgical Robotics Update

    Fine Print: Examining 3D Printing for Orthopedics

    Pulsed Electrochemical Machining: Achieved Through Chemistry

    Packaging and Sterilization Update for Orthopedic Devices
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System

    Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair

    Cionic Expands Scientific Advisory Board

    First Surgeries Performed Using Globus Medical's Excelsius3D

    Envista To Acquire Osteogenics
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Denise Pedulla Appointed as Chief Legal Officer at Conformis

    ODT's Most-Read Stories This Week—May 14

    Steven Haddad Joins Extremity Medical as Chief Clinical Officer

    FDA OKs Accelus' FlareHawk TiHawk11 Interbodies

    Gary Fischetti Joins Conformis’ Board of Directors
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    It’s All About the Data for Supply Chain and Inventory Management

    Minimizing Risks in Minimally Invasive Surgery

    Giving Athletes Their Lives Back with Better Knee Braces

    ODT Forum '22 is Another Successful Orthopedic Tech Conference

    5 Ways AI Will Impact Orthopedic Surgery's Future
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Autocam Medical

    Orchid Orthopedic Solutions

    Tiodize

    Master Bond Inc.

    AV&R
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    The Zimmer-Biomet Deal—Has it Really 'Shaken' Warsaw?

    ...

    The Zimmer-Biomet Deal—Has it Really
    Related CONTENT
    • Accelus Introduces TiHawk9 Expandable Interbody Cage
    • Compamed 2021 Shifts Location to Halls 13 & 14 at the Fairgrounds in Düsseldorf
    • ZimVie Is Zimmer Biomet’s Spine/Dental Spinoff Name; Adds Leadership
    • Miach Ortho Begins BEAR III Post-Market Study
    • Former Stryker Exec Stuart Simpson Named THINK Surgical President, CEO
    Bryan Hughes, Director, P&M Corporate Finance09.20.16
    It’s hard to believe that it’s been more than two years since a series of major acquisitions swept across the medical technology landscape during the first six months of 2014. In April that year, Zimmer Holdings Inc. announced the acquisition of cross-town orthopedic implant rival Biomet Inc. in a $14 billion cash and stock transaction. Less than two months later, Medtronic Inc. and Covidien plc surprised the medical device community by announcing their own $42.9 billion merger. 

    In retrospect, neither deal should have been a surprise. Two years earlier, Johnson & Johnson’s DePuy franchise acquired Synthes Inc. for roughly $21 billion, creating the largest global musculoskeletal device company. And, rumors were swirling for much of 2014 that Stryker Corp., or maybe Medtronic, would acquire Smith & Nephew plc. In fact, for much of the past decade, medical device companies have reshaped their businesses through acquisitions, divestitures, and portfolio realignment. But in 2014, these discussions reached a fever pitch; multiple pharmaceutical and device firms announced transactions to gain scale and potentially tap cash “trapped” offshore through so-called tax inversions. 

    While the potential tax-inversion benefits ultimately hit regulatory roadblocks, medical device firms continued to evaluate multiple non-organic approaches to gain the necessary scale to offset declining pricing power in the market. The subhead to Orthopedic Design & Technology’s 2014 feature on the top 10 orthopedic device firms captured the strategy quite succinctly, noting, “The orthopedic industry’s largest firms adapt to new market realities to survive on top.” In the face of the Affordable Care Act, payers and providers had rapidly consolidated, thus gaining price leverage with firms like Zimmer and Medtronic.

    In covering Zimmer specifically, ODT echoed the above sentiment through various comments from industry analysts. Mike Matson, then at Needham & Co., stated, “There are a lot of cost savings to be had and the scale should provide an advantage as their customers, hospitals, and insurance companies go through waves of consolidation.” Jason McGorman at Bloomberg said the deal gives Zimmer “some leverage when they go to hospitals, and helps them compete,” while Michael Weinstein with J.P. Morgan claimed the merger “further consolidates an industry that has been lacking in pricing power for the past decade. Zimmer is stronger as a result of the transaction—both competitively and relative to a customer base that continues to consolidate and gain leverage over the surgeon.”

    For its part, Zimmer framed the transaction slightly differently, titling its investor presentation on the deal “Combination Creates Leading Innovator in the Musculoskeletal Industry.” While not explicitly addressing the scale motivation outlined above, management did seem to touch on this aspect, as the presentation covered the strategic rationale for the transaction:
    • Establish a broader portfolio of musculoskeletal products, technologies, and services
    • Combine shared heritage of engineering excellence and material science expertise
    • Accelerate pipeline of clinically relevant solutions that address unmet needs
    • Partner with providers, patients, and payers to improve outcomes in a cost-effective manner
    Halfway through the same presentation, transaction synergies took center stage. Like many other large transactions across all industries, Zimmer made the valuation it placed on Biomet work, in part, through setting aggressive synergy targets. The two companies outlined more than $270 million in annual savings to be fully achieved within three years of the transaction. The deal is not unique in its pursuit of such a high level of cost-savings from the combined entities; whether from a seller or buyer perspective, the mention of specific transaction synergies is almost always mentioned in describing a merger transaction. What was unique in this particular deal, however, was that two companies shared an overlapping corporate history, were headquartered only a few miles apart in Warsaw, Ind., and combined, had more than 2 million square feet of corporate and manufacturing facilities in the town of roughly 14,000 people.

    Sometimes cost synergies can make a deal work financially; often they are the strategic justification for pulling the trigger—the classic one plus one equals something greater than two. In medical technology transactions, operational synergies are pervasive, and their impact on manufacturing operations and the medical product outsourcing universe are real.

    In the Zimmer/Biomet transaction, management ultimately increased its net synergy target to $350 million, but on a percentage basis, the target was still similar to other deals announced around the same time. In each transaction, the specific language used to describe the areas of expected cost savings became a bit blurred. However, from back-office redundancies and facility optimization to a shift to lower-cost regions, all functional areas have been outlined as opportunities to achieve meaningful transaction synergies. In Zimmer’s case, most of the synergy savings were expected to come from “disciplined expense management, advanced manufacturing, and streamlined logistics.”  Specific areas highlighted included:
    • Reduce manufacturing lead time
    • Strategic sourcing
    • Streamlined redundancies
    • Natural attrition
    It wasn’t necessarily the synergy targets that led The Wall Street Journal to deem the transaction as the “The Deal That Shook Warsaw,” or the city’s local newspaper, Elkhart Truth, to equate it to an “orthopedic earthquake.” While the cuts required to hit those synergy targets would be acutely felt around the organizations, the broader concerns were whether the two distinct cultures could truly be integrated, and whether the transaction would be the tipping point to drive much deeper cost-cutting initiatives. As an orthopedic executive noted to the Journal, “Biomet employees often wear jeans to work, whereas Zimmer’s corporate reputation is “suit and ties.”

    The story of Biomet’s founding is well known in Warsaw. In 1975 while sailing together, Dane Miller, then the director of biomedical engineering at Zimmer, and his friend and co-worker Jerry Ferguson, began talking about their mutual dissatisfaction with the orthopedic industry’s stifling corporate culture.  Two years later, after bringing in partners Niles Noblitt and Ray Haroff, and all of their wives, Biomet began operations in a converted barn down the street from Zimmer. The founders invested everything they owned in starting the company, and even after Biomet went public in the early 1980s, the small group took on any task to ensure the company was successful. The founders built an entrepreneurial culture where employees were owners and were directly rewarded by the company’s financial performance. 

    Although Zimmer was also considered an entrepreneurial organization, the story of Biomet’s founding led to a dynamic throughout Warsaw where the view of Zimmer’s and Biomet’s cultures often became as distinct as jeans vs. suits. Executives and employees would leave one organization for the other as they regarded the culture and career opportunities to be much better “down the street.” And now the two companies were becoming one.

    In the 15 months since the mega-merger’s closing on June 24, 2015, management has worked very hard to be cognizant of these differences and build on the best of both companies. Early integration teams ballooned to almost 250 people, but importantly, employees of both companies were equally represented. Today, the organizational structure blends leadership from both legacy Zimmer and Biomet organizations and is focused on leveraging the best practices of each across the company. In many business units, sales force integration plans have met primary milestones ahead of schedule and the vision for a customer-first sales culture is generally on track. These conclusions, of course, are strictly my own from an outside perspective; I’m sure many representatives within the organization view things slightly differently but on balance, the integration and goal of building on two distinct cultures seems to be progressing.

    From a synergy perspective, the company accelerated its first year target to $155 million but has not changed its overall target of $350 million. While such initiatives do ultimately impact employees—as has been the case with the closing of Zimmer Dental’s facilities in Carlsbad, Calif.—fears of “the next shoe dropping” have generally not come to fruition. Unlike Medtronic, which announced far-reaching cost-cutting initiatives after acquiring Covidien, Zimmer Biomet has yet to focus on such cuts; long-term guidance outlined at the JP Morgan Healthcare conference earlier this year included only minor COGS (cost of goods sold) and SG&A (selling, general, and administrative) efficiencies through 2020.

    Perhaps most impactful to the industry, and Warsaw, has been the company’s drive to focus on another strategic driver of the transaction—accelerating the pipeline of clinically relevant solutions. In the last 12 months, Zimmer Biomet has been on a bit of an acquisition streak as the company seeks to broaden its product and technology portfolio across all business units.  Specific deals include:
    • LDR Holding Corporation— Expands the portfolio of spinal implants and positions company to capitalize on faster-growing spine segments, including cervical disc replacement.
    • CD Diagnostics— Positions the company as a leader in musculoskeletal diagnostics.
    • Cayenne Medical Inc.— Strengthens Zimmer Biomet’s sports medicine capabilities and portfolio of technically advanced soft tissue reconstruction solutions for knee, shoulder, and extremities procedures.
    • Ortho Transmission LLC— Enhances the company’s ongoing collaboration with the U.S. Department of Defense for the development of a transcutaneous system for anchoring external prosthetic limbs to restore mobility to amputees.
    • Medtech SA— Gives the company a foothold in the surgical robot market; Medtech has developed two robots for minimally invasive brain and spine procedures.
    Time will tell whether these acquisitions will ultimately provide revenue growth across the business. As more time passes since the deal’s closing, there is always a chance the synergy targets will expand. But currently, Zimmer Biomet seems to be moving in the right direction with only minor tremors felt in Warsaw.

    As David Dvorak stated in the company’s most recent earnings call, “Our top line performance, coupled with the ongoing capture of operational synergies, supported investments into strategic growth drivers, while delivering adjusted earnings per share above our guidance range. We will continue to execute on commercial opportunities across our broad portfolio in the second half of the year, as well as expand our clinical offerings with differentiated new technologies, services, and solutions.”  


    Bryan Hughes is a director of PMCF and leads the firm’s medical technology team. His practice focuses on assisting clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation and strategic consulting. His clients have ranged from global medical technology companies to small, privately held businesses. In addition to leading the firm’s medical technology team, Hughes also has completed transactions in the business services, consumer and industrial sectors. He has written numerous articles and is a frequent speaker on healthcare investment banking topics. Hughes earned a BBA with an emphasis in finance from the Stephen M. Ross School of Business at the University of Michigan.
    Related Searches
    • stryker
    • depuy
    • surgeon
    • diagnostics
    Suggested For You
    Accelus Introduces TiHawk9 Expandable Interbody Cage Accelus Introduces TiHawk9 Expandable Interbody Cage
    Compamed 2021 Shifts Location to Halls 13 & 14 at the Fairgrounds in Düsseldorf Compamed 2021 Shifts Location to Halls 13 & 14 at the Fairgrounds in Düsseldorf
    ZimVie Is Zimmer Biomet’s Spine/Dental Spinoff Name; Adds Leadership ZimVie Is Zimmer Biomet’s Spine/Dental Spinoff Name; Adds Leadership
    Miach Ortho Begins BEAR III Post-Market Study Miach Ortho Begins BEAR III Post-Market Study
    Former Stryker Exec Stuart Simpson Named THINK Surgical President, CEO Former Stryker Exec Stuart Simpson Named THINK Surgical President, CEO
    AAOS News: DJO Introduces EMPOWR Dual Mobility Hip System AAOS News: DJO Introduces EMPOWR Dual Mobility Hip System
    Zimmer Biomet, Canary Medical Persona IQ Smart Knee Earns FDA Nod Zimmer Biomet, Canary Medical Persona IQ Smart Knee Earns FDA Nod
    AAOS News: Zimmer Biomet to Present New Clinical Data and Technologies Portfolio AAOS News: Zimmer Biomet to Present New Clinical Data and Technologies Portfolio
    Accelus Debuts Ultra-Low-Profile Expandable Cage Implant Accelus Debuts Ultra-Low-Profile Expandable Cage Implant
    FDA OKs Zimmer Biomet FDA OKs Zimmer Biomet's ROSA Hip
    Medical Device IP Strategy, Part I: Creating a Patent Strategy that Protects Your Revenue Model Medical Device IP Strategy, Part I: Creating a Patent Strategy that Protects Your Revenue Model
    Zimmer Biomet Zimmer Biomet's Q2 Sales Soar 65 Percent
    Bioventus to Acquire Misonix for $518M Bioventus to Acquire Misonix for $518M
    Conformis Settles Patent Litigation with Stryker Conformis Settles Patent Litigation with Stryker
    Integrity Implants, Fusion Robotics Merge to Form Accelus Integrity Implants, Fusion Robotics Merge to Form Accelus

    Related Content

    • Spine/Neurology
      Accelus Introduces TiHawk9 Expandable Interbody Cage

      Accelus Introduces TiHawk9 Expandable Interbody Cage

      TiHawk blends features of PEEK with titanium for a modulus more similar to bone that permits fluoroscopic visualization.
      Globe Newswire 09.21.21

    • Compamed 2021 Shifts Location to Halls 13 & 14 at the Fairgrounds in Düsseldorf

      Compamed 2021 Shifts Location to Halls 13 & 14 at the Fairgrounds in Düsseldorf

      The trade fair will be held concurrently with Medica from November 15-18, 2021.
      Compamed 09.17.21

    • Spine/Neurology
      ZimVie Is Zimmer Biomet’s Spine/Dental Spinoff Name; Adds Leadership

      ZimVie Is Zimmer Biomet’s Spine/Dental Spinoff Name; Adds Leadership

      Richard J. Heppenstall is named as executive vice president and chief financial officer.
      Zimmer Biomet 09.15.21


    • Large Joint
      Miach Ortho Begins BEAR III Post-Market Study

      Miach Ortho Begins BEAR III Post-Market Study

      Enables healing of a patient's torn anterior cruciate ligament (ACL).
      Business Wire 09.13.21

    • Former Stryker Exec Stuart Simpson Named THINK Surgical President, CEO

      Former Stryker Exec Stuart Simpson Named THINK Surgical President, CEO

      Simpson brings his deep understanding of the orthopedics industry and orthopedic surgical robots.
      PR Newswire 09.02.21


      Trending
      • GE Additive And Orchid Partner To Advance Scalable Metal 3D Printing | Orthopedic Design Technology
      • Orthotic Brace Suppliers Convicted In $6.5M Fraud Scheme | Orthopedic Design Technology
      • Orthotic Brace Suppliers Convicted in $6.5M Fraud Scheme
      • Minimizing Risks In Minimally Invasive Surgery | Orthopedic Design Technology
      • Alex Gorsky To Step Down As J&J CEO In 2022 | Orthopedic Design Technology
      Breaking News
      • FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      • Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      • Cionic Expands Scientific Advisory Board
      • First Surgeries Performed Using Globus Medical's Excelsius3D
      • Envista To Acquire Osteogenics
      View Breaking News >
      CURRENT ISSUE

      March/April 2022

      • Innovation Iteration: Latest Advancements in Design & Prototyping
      • Robot Recharge: Orthopedic Surgical Robotics Update
      • Fine Print: Examining 3D Printing for Orthopedics

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Five PPG Facilities in Ohio Recognized for Sustainability, Health, Safety Practices
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      FDA Clears Arterys' AI Mapping and Quantification Tools
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      Silab Implements Biodiversity Conservation Project
      Indie Beauty Brand i-On Skincare Releases New Skin Emulsion, AI Diagnostic Tool
      Estée Lauder Companies' New Research on Oxidative Damage, Skin Barrier Function & Hyperpigmentation
      Ink World

      Latest Breaking News From Ink World

      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Award for Sustainability: Evonik Receives Platinum Rating Again
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nazdar celebrates 100th anniversary with refreshed brand identity
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      'Right' Hygiene Conference to be Held in June
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Cionic Expands Scientific Advisory Board
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell
      eMagin Wins People’s Choice Award at Display Week 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login